BPC-157 to accelerate tissue healing, reduce inflammation, and support gut lining integrity
Examples of such stabilizing agents, include, but are not limited to: (a) about 0.5% to about 2% w/v glycerol, (b) about 0.1% to about 1% w/v methionine, (c) about 0.1% to about 2% w/v monothioglycerol, (d) about 1 mM to about 10 mM EDTA, (e) about 0.01% to about 2% w/v ascorbic acid, (f) 0.003% to about 0.02% w/v polysorbate80, (g) 0.001% to about 0.05% w/v.polysorbate20, (h) arginine, (i) heparin, (j) dextran sulfate, (k) cyclodextrins, (1) pentosan polysulfate and other heparinoids, (m) divalent cations such as magnesium and zinc
Information on BPC-157 Injections Although more definitive studies into the administration of BPC-157 in humans are needed, researchers may benefit from known clinical findings to guide safe and proper handling
TB-500: The Tissue Regeneration Specialist What It Does TB-500 is a synthetic fragment of Thymosin Beta-4 (specifically the LKKTETQ sequence) that excels at tissue regeneration and wound healing
J Alzheimers Dis 2019:517521
